Literature DB >> 4109629

[What is the relevance of various previous lesions of the peripheral nervous system to a thalidomide polyneuropathy?].

G P Liebaldt, F Broser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4109629

Source DB:  PubMed          Journal:  Z Neurol        ISSN: 0012-1037


× No keyword cloud information.
  35 in total

1.  THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS.

Authors:  J SHESKIN
Journal:  Clin Pharmacol Ther       Date:  1965 May-Jun       Impact factor: 6.875

2.  Thalidomide polyneuropathy.

Authors:  S COHEN
Journal:  N Engl J Med       Date:  1962-06-14       Impact factor: 91.245

3.  [Contergan--side effects. Central nervous system manifestations and polyneuritic symptoms in long-term medication with N-phthalyl glutamic acid imide].

Authors:  H FRENKEL
Journal:  Med Welt       Date:  1961-05-06

4.  [Distribution of paralysis in polyneuritis].

Authors:  H WIECK
Journal:  Dtsch Z Nervenheilkd       Date:  1951

5.  [Not Available].

Authors:  W SCHEID
Journal:  Nervenarzt       Date:  1947-02       Impact factor: 1.214

6.  [Thalidomide polyneuropathy. Clinical bioptical studies].

Authors:  F Seitelberger
Journal:  Wien Klin Wochenschr       Date:  1968-01-19       Impact factor: 1.704

7.  [Light and electron microscopic studies of late stages of thalidomide polyneuropathy].

Authors:  W Krücke; H H von Hartrott; J M Schröder; E Thomas; E Gibbels; W Scheid
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1971-01

8.  [Experimental animal studies on the question of thalidomide and nerve damage].

Authors:  M Staemmler; F Lagler
Journal:  Arzneimittelforschung       Date:  1965-05

9.  The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species.

Authors:  H Schumacher; R L Smith; R T Williams
Journal:  Br J Pharmacol Chemother       Date:  1965-10

10.  [Problems of permanent damage in Contergan polyneuropathy and other polyneuropathies or polyneuritides. Results of clinical and electromyographic follow ups].

Authors:  F Broser; H C Hopf; J Hohl
Journal:  Nervenarzt       Date:  1969-01       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.